Products
NEWS DETAILS
Home
>
News
>

Hybrid peptide NTP-217 triggers ROS-mediated rapid necrosis in liver cancer cells by induction of mitochondrial leakage

Hybrid peptide NTP-217 triggers ROS-mediated rapid necrosis in liver cancer cells by induction of mitochondrial leakage

2023-07-06

Latest company news about Hybrid peptide NTP-217 triggers ROS-mediated rapid necrosis in liver cancer cells by induction of mitochondrial leakage

The peptide LTX-315 was synthesized and provided by KS-V Peptide Biological Technology Co., Ltd. (Hefei, China).

Publisher: Qingdao University

Publication: Frontiers in Oncology

Acknowledgment of KS-V Peptide Products: Scientific Research Peptides

Contact Us
Call us

Asia & Pacific: 0551-65120828

Email
sales@ks-vpeptide.com
Address

#A2, National Health Big Data Industrial Park, Hefei, China

About Us
DRUG DISCOVERY STRUCTURAL BIOLOGY PEPTIDES AND PROTEINS HISTONES RESOURCES NEWS ABOUT US
Subscribe Newsletter
Sitemap | Privacy Policy | China Good Quality Proteins Supplier. Copyright © 2023 ks-vpeptide.com . All Rights Reserved.
Contact Us

Asia & Pacific: 0551-65120828
sales@ks-vpeptide.com

#A2, National Health Big Data Industrial Park, Hefei, China

About Us
DRUG DISCOVERY STRUCTURAL BIOLOGY PEPTIDES AND PROTEINS HISTONES RESOURCES NEWS ABOUT US
Subscribe Newsletter
Sitemap | Privacy Policy | China Good Quality Proteins Supplier. Copyright © 2023 ks-vpeptide.com . All Rights Reserved.